U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp cut its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 2.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 531,813 shares of the company's stock after selling 12,907 shares during the quarter. Boston Trust Walden Corp owned approximately 3.53% of U.S. Physical Therapy worth $45,007,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Precision Wealth Strategies LLC lifted its holdings in U.S. Physical Therapy by 5.1% in the 3rd quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company's stock valued at $239,000 after purchasing an additional 137 shares in the last quarter. Texas Permanent School Fund Corp boosted its position in U.S. Physical Therapy by 1.3% during the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company's stock worth $1,480,000 after acquiring an additional 170 shares during the last quarter. First Horizon Advisors Inc. boosted its position in U.S. Physical Therapy by 18.6% during the second quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company's stock worth $110,000 after acquiring an additional 186 shares during the last quarter. Louisiana State Employees Retirement System grew its stake in U.S. Physical Therapy by 2.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company's stock worth $702,000 after acquiring an additional 200 shares during the period. Finally, Martin Capital Advisors LLP raised its holdings in U.S. Physical Therapy by 1.6% in the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company's stock valued at $1,112,000 after acquiring an additional 201 shares during the last quarter.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company's stock, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Kathleen A. Gilmartin bought 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the transaction, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the company's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares of the company's stock, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.70% of the company's stock.

U.S. Physical Therapy Trading Down 1.4 %

U.S. Physical Therapy stock traded down $1.14 during midday trading on Friday, reaching $80.77. The stock had a trading volume of 69,376 shares, compared to its average volume of 89,065. The stock's 50-day simple moving average is $83.14 and its 200 day simple moving average is $92.41. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The stock has a market capitalization of $1.22 billion, a PE ratio of 65.67, a price-to-earnings-growth ratio of 3.94 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). The firm had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The business's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.76 earnings per share. Analysts expect that U.S. Physical Therapy, Inc. will post 2.58 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were given a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 2.18%. The ex-dividend date of this dividend was Friday, August 23rd. U.S. Physical Therapy's payout ratio is currently 143.09%.

Analyst Ratings Changes

USPH has been the subject of a number of recent analyst reports. Barrington Research reaffirmed an "outperform" rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th. Bank of America reaffirmed a "neutral" rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.